成都中医药大学附属医院 成都 610075
Prof. WEI Shaobin, Chief Physician, Doctoral Supervisor. Hospital of Chengdu University of Traditional Chinese Medicine, No.39, Shierqiao Road, Jinniu District, Chengdu 610075. E-mail: wsb2012gcp@163.com
纸质出版日期:2023-09-30,
网络出版日期:2023-07-20,
收稿日期:2023-04-25,
移动端阅览
魏绍斌. 中医药防治盆腔炎性疾病及其后遗症的思路、方法及长期管理策略[J]. 北京中医药大学学报, 2023,46(9):1204-1212.
WEI Shaobin. Thoughts, methods, and long-term management strategies of traditional Chinese medicine in preventing and treating pelvic inflammatory diseases and their sequelae[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(9):1204-1212.
魏绍斌. 中医药防治盆腔炎性疾病及其后遗症的思路、方法及长期管理策略[J]. 北京中医药大学学报, 2023,46(9):1204-1212. DOI: 10.3969/j.issn.1006-2157.2023.09.003.
WEI Shaobin. Thoughts, methods, and long-term management strategies of traditional Chinese medicine in preventing and treating pelvic inflammatory diseases and their sequelae[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(9):1204-1212. DOI: 10.3969/j.issn.1006-2157.2023.09.003.
盆腔炎性疾病及其后遗症是临床上常见的妇科炎性疾病,其病程长且易反复发作,病情复杂,严重影响育龄期女性的生殖健康和生活质量。中医药防治盆腔炎性疾病及其后遗症具有独特优势和特色,急性期采用中西医结合治疗方案,可以起到增效、补充替代和缩短病程的作用;后遗症期采用中医综合疗法及个体化治疗方案,能明显改善患者的症状、体征,有效保护患者生育力。本文结合中医药防治盆腔炎性疾病及其后遗症的思路与方法,提出针对该疾病的长期管理策略,以期进一步规范临床治疗、提高临床疗效、减少疾病复发。
Pelvic inflammatory diseases and their sequelae are common gynecological inflammatory diseases with a long course and propensity for recurrence. Moreover
this condition is complex
which seriously affects the reproductive health and quality of life of women of childbearing age. Traditional Chinese medicine has unique advantages and characteristics in preventing and treating pelvic inflammatory disease and their sequelae. In the acute period
using a combination of traditional Chinese and western medicine treatment plans can increase efficacy and reduce toxicity
mutually supplement and replace
storten the course of the disease. In the sequelae period
the use of traditional Chinese medicine comprehensive therapy can significantly improve symptoms and signs in patients and protect their fertility through multi-pathway and individualized treatment plans. This paper combines the thoughts and methods of traditional Chinese medicine in the prevention and treatment of pelvic inflammatory diseases and their sequelae and also proposes long-term management strategies for this disease in order to further standardize clinical treatment
improve clinical efficacy
and reduce recurrence.
盆腔炎性疾病后遗症中医药防治思路方法长期管理策略
pelvic inflammatory diseasessequelaetraditional Chinese medicine prevention and treatmentthoughts and methodslong-term management strategies
谢幸,孔北华,段涛.妇产科学[M].北京:人民卫生出版社,2018.
KREISEL K, TORRONE E, BERNSTEIN K, et al. Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age - United States, 2013-2014[J].MMWR Morb Mortal Wkly Rep, 2017,66(3):80-83.
李文淑,马杰,倪想,等.已婚女性123 270例妇科疾病检出情况分析[J]. 中国临床保健杂志,2018,21(5):602-604.
ANYALECHI GE, HONG J, KREISEL K, et al. Self-Reported Infertility and Associated Pelvic Inflammatory Disease Among Women of Reproductive Age-National Health and Nutrition Examination Survey, United States,2013-2016[J].Sex Transm Dis,2019,46(7): 446-451.
HUANG CC, HUANG CC, LIN SY, et al. Association of pelvic inflammatory disease(PID) with ectopic pregnancy and preterm labor in Taiwan: A nationwide population-based retrospective cohort study[J/OL].PLoS One, 2019,14(8):e0219351[2023-02-25]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0219351https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0219351.
TRENT M, ELLEN JM, FRICK KD. Estimating the direct costs of pelvic inflammatory disease in adolescents: a within-system analysis[J].Sex Transm Dis,2011,38(4):326-328.
张为,范慧婕,杨芳华,等.基于治未病思想防治盆腔炎性疾病后遗症[J]. 河南中医,2020,40(11):1638-1641.
中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(2019修订版)[J].中华妇产科杂志,2019,54(7):433-437.
WORKOWSKI KA, BACHMANN LH, CHAN PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021[J].MMWR Recomm Rep,2021,70(4):94-97.
马堃,罗颂平,李敏,等.中医药防治盆腔炎性疾病优势与证据研究进展[J]. 中国中药杂志,2017,42(8):1449-1454.
赵多爱,赵晓燕,周蕾,等.金昌市女性盆腔炎病原菌谱及耐药性分析[J]. 国际检验医学杂志,2020,41(16):2024-2027.
张瑜,张洋,崔福鑫,等.急性盆腔感染妇女的病原菌与药物敏感性研究[J]. 中国医药科学,2019,9(15):146-148.
中华中医药学会.中医药单用/联合抗生素治疗常见感染性疾病临床实践指南·盆腔炎性疾病:T/CACM 010—2017[S]. 北京:中国中医药出版社,2017.
国家中医药管理局医政司.22个专业95个病种中医诊疗方案(合订本)[M]. 北京:国家中医药管理局医政司,2010: 531-541.
国家中医药管理局医政司.24个专业92个病种中医诊疗方案[M].北京: 国家中医药管理局医政司,2017:417-427.
《中成药治疗优势病种临床应用指南》标准化项目组.中成药治疗盆腔炎性疾病后遗症临床应用指南(2020年)[J]. 中国中西医结合杂志,2021,41(3):286-299.
张宗敏,杜鑫,王军,等.红藤解毒灌肠方治疗慢性盆腔炎疗效及其对血清MCP-1、IL-1β、TGF-β1表达的影响[J]. 世界中西医结合杂志,2021,16(2):372-375.
吴婷婷.中药藤包外敷联合静脉抗炎治疗慢性盆腔炎的临床疗效观察[J]. 现代医学与健康研究电子杂志,2021,5(13):86-88.
李景溪,王莲莲,施展,等.中药离子导入治疗慢性盆腔炎伴盆腔痛的临床研究[J]. 中国医药导刊,2017,19(6):592-593.
中华中医药学会.中医妇科常见病诊疗指南[M]. 北京:中国中医药出版社,2012.
黄滢. 穴位埋线联合四黄水蜜治疗慢性盆腔炎的临床研究[D].广州:广州中医药大学,2021.
石玲,邓琳雯,魏绍斌.湿热瘀结型盆腔炎中医综合治疗方案的标准化研究[J]. 时珍国医国药,2015,26(12):2961-2962.
王晨亦.益气清湿化瘀综合疗法干预PID反复发作患者的疗效研究[D]. 成都:成都中医药大学,2020.
魏绍斌,罗梅,尹小兰,等.从TLR2/4正负免疫通路探讨益气清湿化瘀法调节PID反复发作患者免疫稳态的影响[J]. 时珍国医国药,2019,30(10):2310-2313.
尹小兰,罗梅,周丽,等.基于TLRs/MyD88通路探讨益气清湿化瘀法治疗气虚血瘀夹湿证盆腔炎性疾病反复发作疗效及机制[J]. 中华中医药杂志,2019,34(8):3846-3850.
罗梅.益气清湿化瘀综合疗法调控盆腔炎性疾病反复发作TLRs/Gas6正负通路免疫稳态的作用及机制[D].成都:成都中医药大学,2019.
朱淑仪.益气清湿化瘀法治疗盆腔炎性疾病反复发作的疗效评价及调控TLR7/9、MyD88及IL-6表达的机制研究[D]. 成都:成都中医药大学,2019.
刘丽,袁孟珂,陈婧,等.针药联合治疗输卵管炎性不孕症临床观察[J]. 辽宁中医药大学学报,2020,22(8):4-7.
Centers for Disease Control and Prevention, WORKOWSKI KA, BERMAN SM. Sexually transmitted diseases treatment guidelines, 2006 [J].MMWR Recomm Rep,2006,55(11):1-94.
WORKOWSKI KA, BERMAN S, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010[J].MMWR Recomm Rep,2010,59(12):1-110.
李婷,刘朝晖.中美盆腔炎性疾病的诊治规范对比解读[J].中国医药导报,2023,20(3):88-92.
中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(修订版)[J].中华妇产科杂志,2014,49(6):401-403.
路遥,楼姣英,冯晓玲,等.妇炎舒胶囊联合抗菌药物治疗盆腔炎性疾病的有效性及安全性:一项随机对照临床研究[J]. 中国妇产科临床杂志,2021,22(4):383-385.
黄贤华,郑南芝,欧阳,等.金英胶囊对慢性盆腔炎湿热证的多中心临床观察[J]. 湖南中医药大学学报,2011,31(7):43-45.
高金鸟,黄秀锦,李芳,等.五味消毒饮合大黄牡丹皮汤加减联合西药治疗急性盆腔炎的临床疗效观察[J]. 中国中医基础医学杂志,2017,23(10):1422-1426.
武俊丽,魏少奔,王宇慧.银甲丸联合乳酸左氧氟沙星治疗盆腔炎的临床效果[J].临床医学研究与实践,2019,4(10):141-143.
罗梅,魏绍斌,黄利,等.康妇消炎栓联合抗生素治疗盆腔炎性疾病的系统评价和Meta分析[J].中国抗生素杂志,2019,44(4):519-526.
黄利.从KLF4调控TLRs/MyD88通路探讨妇炎舒胶囊抗炎机制及清湿化瘀类中成药治疗SPID的系统评价[D]. 成都:成都中医药大学,2020.
覃倩,李彤,尤剑鹏,等.盆腔炎鼠类模型构建与评价[J]. 上海交通大学学报(医学版),2019,39(10):1218-1222.
李雪,刘金星,师伟,等.盆腔炎性疾病后遗症动物手术方法建模的评价和研究[J]. 中华中医药杂志,2017,32(4):1677-1679.
刘晶晶,路莉,陈秀慧,等.盆腔炎性疾病免疫学发病机制的研究进展[J].现代妇产科进展,2014,23(1):64-66.
李茂雅.基于细胞凋亡机制探讨妇炎舒胶囊对PID模型大鼠Bax、Bcl-xL、Caspase-3、PBEF的影响[D]. 成都:成都中医药大学,2020.
张锁,贾瑞林,陈晶.薏苡附子败酱散加味对盆腔炎性疾病后遗症模型大鼠JNK/p38信号通路表达影响[J]. 中华中医药杂志,2022,37(6):3584-3589.
姚春娣,朱澄漪,温玲,等.膈下逐瘀汤对慢性盆腔炎大鼠TLR4/NF-κB信号的影响[J]. 中成药,2020,42(11):2896-2902.
齐进,崔颖娜.金刚藤多糖对慢性盆腔炎大鼠炎症介质、细胞凋亡及免疫细胞功能的影响[J]. 海南医学院学报,2018,24(13):1219-1221.
郭婧,滕秀香,胡晶,等.924例慢性盆腔炎患者中医证型分布与影响因素分析[J]. 北京中医药,2019,38(7):707-710.
李文彬,谢文,魏超容.生活方式干预配合中药保留灌肠对慢性盆腔炎的疗效观察[J]. 中国医药导报,2008,5(19):81-82.
张为,范慧婕,杨芳华,等.基于治未病思想防治盆腔炎性疾病后遗症[J]. 河南中医,2020,40(11):1638-1641.
魏绍斌, 王妍. 防治慢性盆腔炎反复发作的相关对策探讨[J]. 辽宁中医杂志, 2006, 33(9):1101-1102.
0
浏览量
12
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构